Generic drug companies in the U.S. could face an uphill — and costly — legal battle after a new lawsuit filed last week resurfaced collusion allegations. On Friday, a subsidiary of UnitedHealth, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results